Moreover, the prognostic value of nestin for patients with cancer has been widely validated in various solid tumors, such as epithelial ovarian cancer [46], non-small cell lung cancer [47], glioma [48, 49], etc. However, the prognostic and clinicopathological value of nestin in breast cancer patients remained controversial. The gene discussed is NES; the disease is central nervous system cancer.